KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • Fasika from Ethiopia

    IMPAACT4C19

    IMproving Public health outcomes through enhancing Accelerated Access to Care and Treatment innovation for COVID-19 (IMPAACT4C19) project Leveraging KNCV’s expertise…

    Lees meer
  • 03/08/2023

    Stigma Reduction Intervention for HCWs webinar: Introduction to Allies Approach

    You are invited to the Stigma Reduction Intervention for HCWs webinar: Introduction to Allies Approach.The Allies Approach is designed as…

    Lees meer
  • Kristin testmethode

    PANGenS

    Using genome sequencing to understand disease aetiology, dynamics of disease transmission, and the evolution of drug-resistant pathogens. The…

    Lees meer
  • SMART4TB

    Supporting the implementation of TB research activities to evaluate novel approaches, interventions, and tools to combat TB. SMART4TB (Supporting, Mobilizing,…

    Lees meer
  • Man met ezel

    21/07/2023

    New study: Without TB prevention, tuberculosis will result in close to 1 million deaths by 2035

    Combination intervention found to be cost-effective in averting illness and deaths in high-risk groups People living in close…

    Lees meer
  • 30/06/2023

    A poem about tuberculosis: ‘The silent battles you fought’

    This poem was written by Kinjal Sanghavi, a talented poetess from India. One of her close friends fell ill with…

    Lees meer
  • 29/06/2023

    KNCV Annual Report 2022 presented to Her Royal Highness Princess Margriet

    Executive Director of KNCV Tuberculosis Foundation, Dr. Gidado Mustapha, presented the 2022 annual report to Her Royal Highness (HRH)…

    Lees meer
  • 28/06/2023

    Reimagining Emily Brontë’s state of mind dying of tuberculosis

    It has almost been 175 years since Emily Brontë, the English novelist best known for ‘Wuthering Heights’, died of tuberculosis…

    Lees meer
  • 17/05/2023

    Saying goodbye and welcoming: two long esteemed colleagues

    Today we are saying goodbye to Jan Hendrik Richardus, Vice-Chair of the Board of Trustees (BoT) of…

    Lees meer
  • 06/04/2023

    Investing in TB vaccine research and development can save millions of lives

    Despite progress in TB control efforts, the global burden of TB remains high, with an estimated 10.6 million new cases…

    Lees meer
  • 04/04/2023

    Join us for a Round Table Discussion on BPaLM/BPaL

    On 12 April 2023, KNCV TB Plus will conduct an online Round Table Discussion on ‘Experience sharing: Preparation for programmatic…

    Lees meer
  • 30/03/2023

    KNCV Ethiopia’s Contributions and Recognition during the 17th Annual TB Research Conference (TRAC)

    KNCV TB Plus Ethiopia participated in 17th annual tuberculosis (TB) research conference (TRAC) and in the World TB Day commemoration, which…

    Lees meer
  • 24/03/2023

    250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries

    Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will…

    Lees meer
  • 24/03/2023

    Technical Brief: 5 Country Experiences with Digital Adherence Technologies

    Today is World TB Day, with Yes, We Can End TB as the theme for 2023. Digital Adherence Technologies (DATs)…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.